Track topics on Twitter Track topics that are important to you
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1[5 [aminoiminomethylamino]1oxo2[[1,2,3,4tetrahydro3methyl8quinolinylsulfonyl]amino]pentyl]4methyl2piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration stereoisomer Type I and an S configuration stereoisomer Type II. Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
The global Argatroban market will reach xxx Million USD in 2017 with CAGR xx% from 20182025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export import
Key manufacturers manufacturing sites, capacity and production, product specifications etc.
Average market price by SUK
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries
Major applications as follows:
Heparininduced thrombocytopenia HIT
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
Regional market size, production data and export import:
Middle East Africa
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...